104 related articles for article (PubMed ID: 21194999)
1. Relaxed complex scheme suggests novel inhibitors for the lyase activity of DNA polymerase beta.
Barakat K; Tuszynski J
J Mol Graph Model; 2011 Feb; 29(5):702-16. PubMed ID: 21194999
[TBL] [Abstract][Full Text] [Related]
2. Solution structure of the lyase domain of human DNA polymerase lambda.
DeRose EF; Kirby TW; Mueller GA; Bebenek K; Garcia-Diaz M; Blanco L; Kunkel TA; London RE
Biochemistry; 2003 Aug; 42(32):9564-74. PubMed ID: 12911298
[TBL] [Abstract][Full Text] [Related]
3. Sulfoquinovosylmonoacylglycerol inhibitory mode analysis of rat DNA polymerase beta.
Kasai N; Mizushina Y; Murata H; Yamazaki T; Ohkubo T; Sakaguchi K; Sugawara F
FEBS J; 2005 Sep; 272(17):4349-61. PubMed ID: 16128805
[TBL] [Abstract][Full Text] [Related]
4. Structural relationship of lithocholic acid derivatives binding to the N-terminal 8-kDa domain of DNA polymerase beta.
Mizushina Y; Kasai N; Miura K; Hanashima S; Takemura M; Yoshida H; Sugawara F; Sakaguchi K
Biochemistry; 2004 Aug; 43(33):10669-77. PubMed ID: 15311928
[TBL] [Abstract][Full Text] [Related]
5. Modulation of cellular response to cisplatin by a novel inhibitor of DNA polymerase beta.
Boudsocq F; Benaim P; Canitrot Y; Knibiehler M; Ausseil F; Capp JP; Bieth A; Long C; David B; Shevelev I; Frierich-Heinecken E; Hübscher U; Amalric F; Massiot G; Hoffmann JS; Cazaux C
Mol Pharmacol; 2005 May; 67(5):1485-92. PubMed ID: 15703384
[TBL] [Abstract][Full Text] [Related]
6. Structural insights on the pamoic acid and the 8 kDa domain of DNA polymerase beta complex: towards the design of higher-affinity inhibitors.
Hazan C; Boudsocq F; Gervais V; Saurel O; Ciais M; Cazaux C; Czaplicki J; Milon A
BMC Struct Biol; 2008 Apr; 8():22. PubMed ID: 18416825
[TBL] [Abstract][Full Text] [Related]
7. Backbone dynamics and refined solution structure of the N-terminal domain of DNA polymerase beta. Correlation with DNA binding and dRP lyase activity.
Maciejewski MW; Liu D; Prasad R; Wilson SH; Mullen GP
J Mol Biol; 2000 Feb; 296(1):229-53. PubMed ID: 10656829
[TBL] [Abstract][Full Text] [Related]
8. DNA polymerase beta (pol β) inhibitors: a comprehensive overview.
Barakat KH; Gajewski MM; Tuszynski JA
Drug Discov Today; 2012 Aug; 17(15-16):913-20. PubMed ID: 22561893
[TBL] [Abstract][Full Text] [Related]
9. Site-directed mutational analysis of structural interactions of low molecule compounds binding to the N-terminal 8 kDa domain of DNA polymerase beta.
Murakami S; Kamisuki S; Takata K; Kasai N; Kimura S; Mizushina Y; Ohta K; Sugawara F; Sakaguchi K
Biochem Biophys Res Commun; 2006 Nov; 350(1):7-16. PubMed ID: 16996474
[TBL] [Abstract][Full Text] [Related]
10. Recognition of template-primer and gapped DNA substrates by the human DNA polymerase beta.
Rajendran S; Jezewska MJ; Bujalowski W
J Mol Biol; 2001 May; 308(3):477-500. PubMed ID: 11327782
[TBL] [Abstract][Full Text] [Related]
11. DNA polymerase beta lyase inhibitors from Maytenus putterlickoides.
Feng X; Gao Z; Li S; Jones SH; Hecht SM
J Nat Prod; 2004 Oct; 67(10):1744-7. PubMed ID: 15497954
[TBL] [Abstract][Full Text] [Related]
12. Identification of small molecule synthetic inhibitors of DNA polymerase beta by NMR chemical shift mapping.
Hu HY; Horton JK; Gryk MR; Prasad R; Naron JM; Sun DA; Hecht SM; Wilson SH; Mullen GP
J Biol Chem; 2004 Sep; 279(38):39736-44. PubMed ID: 15258144
[TBL] [Abstract][Full Text] [Related]
13. Human DNA polymerase lambda diverged in evolution from DNA polymerase beta toward specific Mn(++) dependence: a kinetic and thermodynamic study.
Blanca G; Shevelev I; Ramadan K; Villani G; Spadari S; Hübscher U; Maga G
Biochemistry; 2003 Jun; 42(24):7467-76. PubMed ID: 12809503
[TBL] [Abstract][Full Text] [Related]
14. Catalytic center of DNA polymerase beta for excision of deoxyribose phosphate groups.
Matsumoto Y; Kim K; Katz DS; Feng JA
Biochemistry; 1998 May; 37(18):6456-64. PubMed ID: 9572863
[TBL] [Abstract][Full Text] [Related]
15. Dideoxynucleoside triphosphate-sensitive DNA polymerase from rice is involved in base excision repair and immunologically similar to mammalian DNA pol beta.
Sarkar SN; Bakshi S; Mokkapati SK; Roy S; Sengupta DN
Biochem Biophys Res Commun; 2004 Jul; 320(1):145-55. PubMed ID: 15207714
[TBL] [Abstract][Full Text] [Related]
16. Structural relationship of curcumin derivatives binding to the BRCT domain of human DNA polymerase lambda.
Takeuchi T; Ishidoh T; Iijima H; Kuriyama I; Shimazaki N; Koiwai O; Kuramochi K; Kobayashi S; Sugawara F; Sakaguchi K; Yoshida H; Mizushina Y
Genes Cells; 2006 Mar; 11(3):223-35. PubMed ID: 16483311
[TBL] [Abstract][Full Text] [Related]
17. Characterization of an inhibitory dynamic pharmacophore for the ERCC1-XPA interaction using a combined molecular dynamics and virtual screening approach.
Barakat KH; Torin Huzil J; Luchko T; Jordheim L; Dumontet C; Tuszynski J
J Mol Graph Model; 2009 Sep; 28(2):113-30. PubMed ID: 19473860
[TBL] [Abstract][Full Text] [Related]
18. NMR determination of lysine pKa values in the Pol lambda lyase domain: mechanistic implications.
Gao G; DeRose EF; Kirby TW; London RE
Biochemistry; 2006 Feb; 45(6):1785-94. PubMed ID: 16460025
[TBL] [Abstract][Full Text] [Related]
19. Structural insight into the DNA polymerase beta deoxyribose phosphate lyase mechanism.
Prasad R; Batra VK; Yang XP; Krahn JM; Pedersen LC; Beard WA; Wilson SH
DNA Repair (Amst); 2005 Dec; 4(12):1347-57. PubMed ID: 16172026
[TBL] [Abstract][Full Text] [Related]
20. Simulations of DNA pol lambda R517 mutants indicate 517's crucial role in ternary complex stability and suggest DNA slippage origin.
Foley MC; Schlick T
J Am Chem Soc; 2008 Mar; 130(12):3967-77. PubMed ID: 18307346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
